Tag: floor

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition, Humacyte has granted the underwriters an option for a period of 30 days to purchase up to an additional 7,142,857 shares of Humacyte’s common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being sold by Humacyte.

The Coushatta Tribe of Louisiana will host its 29th annual powwow June 12 to 13, 2026, at The Pavilion at Coushatta Casino Resort in Kinder, Louisiana.

New York's 118-Year-Old Sports Specialty icon Doubles Down on the City It Was Built For–With Brand Build-Outs, a Reimagined Store Experience, and a Championship...

NEW YORK, June 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Lucid Group, Inc. (NASDAQ: LCID) between February 25, 2026 and April 13, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 28, 2026.

Alaska Airlines and Microsoft join Twelve to mark commercial operation of AirPlant One — the first plant in the United States to produce E-Jet...

The bar will be one of many amenities at the condo-residence hotel that will redefine luxury living in the heart of San Juan’s Financial District

The bar will be one of many amenities at the condo-residence hotel that will redefine luxury living in the heart of San Juan’s Financial District

The celebration in Turku, Finland, marked the official handover of the ship to the vacation brand ahead of a July 2026 European debutMIAMI, June...

The celebration in Turku, Finland, marked the official handover of the ship to the vacation brand ahead of a July 2026 European debutMIAMI, June...

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 10, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides...

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 10, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides...

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 10, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides...

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, June 10, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides...

Company brings Amaze Commerce and The Food Channel to VidCon 2026, showcasing to creators how to build sustainable business around their content

Company brings Amaze Commerce and The Food Channel to VidCon 2026, showcasing to creators how to build sustainable business around their content

AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking antibodies for the treatment of patients with inflammatory and immune-mediated diseases, today announced the pricing of its previously announced a public offering of 10,879,376 shares of its common stock at a public offering price per share of $4.00 and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 7,870,624 shares of its common stock at a public offering price of $3.9999 per pre-funded warrant. The pre-funded warrants have an exercise price of $0.0001 per share and are exercisable immediately. The aggregate gross proceeds to Shattuck from the offering are expected to be approximately $75 million before deducting underwriting discounts and commissions and other offering expenses payable by Shattuck, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on June 11, 2026, subject to the satisfaction of customary closing conditions. In addition, Shattuck has granted the underwriters an option for a period of 30 days to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions.